Online
Glenmark Pharma
BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 | Pharmaceuticals
Buy Glenmark Pharma, target of Rs 274: KR Choksey
KR Choksey has come out with a report on Glenmark Pharmaceuticals' Q2FY10 earnings. The research firm valued the company at FY11E P/E multiple of 16x,...
04-11-2009
Glenmark
Buy Glenmark Pharma, target of Rs 274: KR Choksey
KR Choksey has come out with a report on Glenmark Pharmaceuticals' Q2FY10 earnings. The research firm valued the company at FY11E P/E multiple of 16x,...
04-11-2009
16-09-2009: Hold Glenmark Pharma, target of Rs 251: Sharekhan
20-08-2009: Hold Glenmark Pharma, target of Rs 211: Emkay
20-08-2009: Hold Glenmark Pharma, target of Rs 251: Sharekhan
04-07-2009: Buy Glenmark Pharma; target of Rs 252: KRChoksey
Buy Cipla, target of Rs 370: Hem Securities
Hem Securities has come out with a research report on Cipla. The research firm has initiated a buy signal on the stock with a target price of Rs 370 i...
10-11-2009
10-11-2009: Daiichi says to help Ranbaxy overcome US FDA woes
09-11-2009: AstraZeneca takes Lupin to NJ court over Nexium
07-11-2009: Dr Reddy's files for marketing Lipitor generic
06-11-2009: Sun Pharma underperformer, target Rs 1355: Karvy
Peers
Buy Cipla, target of Rs 370: Hem Securities
Hem Securities has come out with a research report on Cipla. The research firm has initiated a buy signal on the stock with a target price of Rs 370 i...
10-11-2009
06-11-2009: Sun Pharma underperformer, target Rs 1355: Karvy
04-11-2009: Hold Cipla, target Rs 335: KR Choksey
30-10-2009: Hold Sun Pharma; target of Rs 1422: Sharekhan
29-10-2009: Dr Reddy's Labs an outperformer, target of Rs 1200: Karvy
30-10-2009: Glenmark Pharma net dips 31 percent
30-10-2009: Glenmark net profit drops by 31% to Rs80.88 crore
29-10-2009: Glenmark Pharmaceuticals may improve performance in Oct-Mar
29-10-2009: Stocks to watch: Indian Hotels, HCL Info,Mercator Lines,Autoline Ind,Patel Engineering,Power Grid,HBL Power
28-10-2009: Stocks to watch: Vishal Retail, Binani Cement, SCI, Premier Explosives, Sasken Communications, HCL, Ispat
15-10-2009: Mkts dip; selling in IT, FMGC, banking continuedThursday, October 15, 2009,10:14 [IST]
15-10-2009: USFDA bar on Glenmark�s pain killers
15-10-2009: Glenmark Generics to stop selling codeine sulphate in US
14-10-2009: Glenmark Pharma plans to list its generics subsidiary
13-10-2009: FIIs pitch tent here, lap up blue chips
11-10-2009: Over 60 companies await SEBI nod for share sale worth Rs 50,000 cr
11-10-2009: Over 50% companies listed in 2 years trading below issue price
11-10-2009: Over 50% firms listing in 2 yrs trading below issue price
08-10-2009: Too pricey, too vague? QIPs in cloud
07-10-2009: Argentina, India to ink pacts during Prez visit
06-10-2009: Sector update: Pharmaceuticals
05-10-2009: Glenmark Pharma unit plans 5.75-bln-rupee IPO
04-10-2009: Glenmark Generics listing unlocks value for parent
04-10-2009: Glenmark Generics aims to raise Rs 570 cr through IPO
02-10-2009: Glenmark Generics files DRHP with SEBI
10-11-2009: Emergency pills to maintain OTC drug status
08-11-2009: Recovery tempered by challenges
06-11-2009: Sensex: Hat-trick of gains
06-11-2009: Sensex ends above 16k mark; SBI, ITC gainThursday, November 5, 2009,10:23 [IST]
10-11-2009: Emergency pills to maintain OTC drug status
07-11-2009: Cholesterol drug sales set to double
03-11-2009: Nifty ends below 4550; Suzlon,Hindalco,DLF fall
03-11-2009: Nifty consolidates; Bajaj, Bharti upTuesday, November 3, 2009,10:15 [IST]
03-11-2009: EU seizes another generic package
23-10-2009: Dr.Reddy's Lab net profit rises 116.52 percent
23-10-2009: Dr.Reddy's Lab net profit rises 116.52 percent
23-10-2009: Dr.Reddy's Lab net profit rises 116.52 percent
07-11-2009: Nifty ends higher; Suzlon, Jaiprakash gainFriday, November 6, 2009,10:17 [IST]
31-10-2009: Sensex entrenched in consolidation zone, loses 5.44 percent in week
31-10-2009: Sensex loses 5.44 percent in week
31-10-2009: Sensex entrenched in consolidation zone, loses 5.44 percent in week
09-11-2009: Generics Gateway
07-11-2009: HHS Orders Intravenous Antiviral Flu Medication To Help Patients Hospitalized With 2009 H1N1
07-11-2009: Theravance And Astellas Announce The Commercial Launch Of VIBATIVTM (telavancin) In The United States
07-11-2009: Aurobindo drug gets US nod
